No Data
No Data
Dentsu Group revised downwards to 107.1 billion yen in operating profit, from 135.4 billion yen on 24 December.
Dentsu Group (4324) announced a revision of its financial estimates for the fiscal year ending in December 2024, lowering its operating profit from 135.4 billion yen to 107.1 billion yen due to anticipated revenue deficits in Asia-Pacific regions such as China and Australia, resulting in impairment losses. Additionally, expenses related to the sale of its business in Russia, against the background of the Ukrainian invasion, have exceeded expectations. Plus evaluation: Skylark (3197), Medpeer (6095), Yonshan Holdings (3962).
Linical Co. Faces Q1 Downturn but Forecasts Strong Year
Linical: Supplementary explanation materials for the first quarter financial results for March 2025.
Linical: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.
Skylark, Dentsu G, Ebara, Asahi Intec (14th)
*The above calendar is subject to change due to company circumstances. --------------------------------------- August 14th (Wed) <1380> Akikawa Bokuen <1443> GikenHD <147A> Solacom <1491> Chugai Mining <149A> Shinka <157A> Green Monster <160A> Az Partners <1711> SDSHD 1
Linical Nommée Meilleure CRO Mondiale Par Le Magazine Global Health & Pharma
No Data